1. Home
  2. ETD vs ABUS Comparison

ETD vs ABUS Comparison

Compare ETD & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETD
  • ABUS
  • Stock Information
  • Founded
  • ETD 1932
  • ABUS N/A
  • Country
  • ETD United States
  • ABUS United States
  • Employees
  • ETD N/A
  • ABUS N/A
  • Industry
  • ETD Home Furnishings
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETD Consumer Discretionary
  • ABUS Health Care
  • Exchange
  • ETD Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • ETD 781.8M
  • ABUS 697.3M
  • IPO Year
  • ETD 1993
  • ABUS N/A
  • Fundamental
  • Price
  • ETD $28.32
  • ABUS $3.21
  • Analyst Decision
  • ETD Hold
  • ABUS Strong Buy
  • Analyst Count
  • ETD 2
  • ABUS 4
  • Target Price
  • ETD $31.00
  • ABUS $5.50
  • AVG Volume (30 Days)
  • ETD 157.5K
  • ABUS 781.8K
  • Earning Date
  • ETD 01-22-2025
  • ABUS 11-06-2024
  • Dividend Yield
  • ETD 2.74%
  • ABUS N/A
  • EPS Growth
  • ETD N/A
  • ABUS N/A
  • EPS
  • ETD 2.48
  • ABUS N/A
  • Revenue
  • ETD $636,666,000.00
  • ABUS $6,742,000.00
  • Revenue This Year
  • ETD N/A
  • ABUS N/A
  • Revenue Next Year
  • ETD $2.46
  • ABUS N/A
  • P/E Ratio
  • ETD $11.57
  • ABUS N/A
  • Revenue Growth
  • ETD N/A
  • ABUS N/A
  • 52 Week Low
  • ETD $26.53
  • ABUS $2.21
  • 52 Week High
  • ETD $35.62
  • ABUS $4.72
  • Technical
  • Relative Strength Index (RSI)
  • ETD 35.91
  • ABUS 33.77
  • Support Level
  • ETD $29.33
  • ABUS $3.13
  • Resistance Level
  • ETD $30.49
  • ABUS $3.61
  • Average True Range (ATR)
  • ETD 0.73
  • ABUS 0.17
  • MACD
  • ETD -0.24
  • ABUS -0.03
  • Stochastic Oscillator
  • ETD 1.93
  • ABUS 12.12

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Share on Social Networks: